Fargo, ND, United States of America

Nathan Russart

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Aldevron, LLC. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathan Russart: Innovator in Synthetic Circular Nucleic Acid Production

Introduction

Nathan Russart is a notable inventor based in Fargo, ND (US). He has made significant contributions to the field of synthetic biology, particularly in the area of nucleic acid production. His innovative approach has the potential to advance various applications in biotechnology and medicine.

Latest Patents

Nathan Russart holds a patent for a "Cell-free method of producing synthetic circular nucleic acid." This patent describes a process of cell-free circular nucleic acid amplification using rolling circle amplification. This method represents a breakthrough in the efficient production of nucleic acids, which are essential for numerous biological applications.

Career Highlights

Nathan is currently employed at Aldevron, LLC, a company known for its expertise in nucleic acid production and related technologies. His work at Aldevron has allowed him to further develop his innovative ideas and contribute to the company's mission of advancing genetic medicine.

Collaborations

Nathan collaborates with talented professionals in his field, including Denis Arutyunov and Venkata Indurthi. These collaborations enhance the research and development efforts at Aldevron, fostering an environment of innovation and creativity.

Conclusion

Nathan Russart is a pioneering inventor whose work in synthetic circular nucleic acid production is paving the way for advancements in biotechnology. His contributions are significant and reflect the importance of innovation in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…